Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company focused ...

By adjusting the fat levels in mRNA-based drugs, researchers have found a way to bypass the liver and go straight to the ...

A new LNP-mRNA vaccine significantly boosts immune response and enhances BCG protection against tuberculosis, offering a ...

New research from the Perelman School of Medicine at the University of Pennsylvania suggests that a combination of messenger ...

The Trump administration has started quietly re-hiring some of the FDA employees that it fired last week in a process that ...

RNA-based therapeutics have rapidly emerged over the past decade, offering a new class of medicines that differ significantly from conventional drugs. These therapies can be programmed to target or ...

A combination of mRNA and a new lipid nanoparticle could help heal damaged lungs, according to new research from the Perelman ...

The concept of using vaccines to treat cancers has been around for several decades. A vaccine was first approved for prostate ...

Precision BioSciences reports early PBGENE-HBV trial data showing safety and antiviral activity in chronic Hepatitis B patients, with more results expected in 2025.

Nanoparticle characterization is vital for mRNA vaccine efficacy, ensuring safety and regulatory compliance in the ...

Gene editing techniques may one day allow for the removal of the extra chromosome that causes Down syndrome, early ...

Genprex (GNPX) announced the advancement of its diabetes program through a strategic collaboration with a contract development and ...